Five children with M4 or M5 acute myelogenous leukemia (AML) not responding to previous treatment or in relapse were treated with a four-drug protocol consisting of cyclophosphamide, adriamycin, vincristine, prednisone, and CNS prophylaxis. There were two treatment failures; the remaining three patients have achieved complete remission, lasting 18+, 13+, and 12+ months respectively. Further follow-up is to be performed.
CITATION STYLE
Urasiński, T., & Podraza, W. (1987). CHOP treatment of childhood acute myelogenous leukemia with monocytic differentiation: a report on five cases. Haematology and Blood Transfusion, 30, 403–405. https://doi.org/10.1007/978-3-642-71213-5_69
Mendeley helps you to discover research relevant for your work.